Search results
Jan 5, 2011 · Get all the information on Natco Pharma with historic price charts for NSE / BSE. Experts & Broker view also get the Natco Pharma Ltd. buy/sell tips detailed news, announcements, Forecasts ...
Get the latest Natco Pharma Ltd. (NATCOPHARM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
2 days ago · Natco Pharma Share Price Today (05 Jul, 2024): Natco Pharma Stock Price (₹ 1223.90) Live NSE/BSE updates on The Economic Times. Check out why Natco Pharma share price is up today. Get all details on Natco Pharma Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Natco Pharma Limited Stock Price Today, Live NSE Share Price: Get the latest Natco Pharma Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Share Price: - The current share price of Natco Pharma is Rs 1217.05. One can use valuation calculators of ticker to know if Natco Pharma share price is undervalued or overvalued.
Get the latest Natco Pharma Ltd. (524816) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
3 days ago · Natco Pharma Share Price - Get NSE / BSE Natco Pharma Stock Price with Fundamentals, Company details, Market Cap, Financial ratio & more at Upstox.com.
Natco Pharma is trading 2.90 % upper at Rs 1,227.75 as compared to its last closing price. Natco Pharma has been trading in the price range of 1,228.55 & 1,182.25. Natco Pharma has given...
Find the latest NATCO Pharma Limited (NATCOPHARM.NS) stock quote, history, news and other vital information to help you with your stock trading and investing.
3 days ago · Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products.
